Comment on "Analysis of Pharmacokinetic and Pharmacodynamic Parameters in EU-Versus US-Licensed Reference Biological Products: Are In Vivo Bridging Studies Justified for Biosimilar Development?" [PDF]
BioDrugs, 2019 Webster CJ, Woollett GR.
europepmc +1 more source
Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary. [PDF]
Clin Pharmacol Ther, 2017 Wang J +19 more
europepmc +1 more source
Evaluating and Reporting the Immunogenicity Impacts for Biological Products--a Clinical Pharmacology Perspective. [PDF]
AAPS J, 2016 Wang YM +5 more
europepmc +1 more source
Pharmacist Substitution of Biological Products: Issues and Considerations. [PDF]
J Manag Care Spec Pharm, 2015 Li E, Ramanan S, Green L.
europepmc +1 more source
Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market. [PDF]
Einstein (Sao Paulo), 2018 Scheinberg MA +4 more
europepmc +1 more source
Perceptions of patients with rheumatic diseases on the impact on daily life and satisfaction with their medications: RHEU-LIFE, a survey to patients treated with subcutaneous biological products. [PDF]
Patient Prefer Adherence, 2017 González CM +6 more
europepmc +1 more source
Biological products for the treatment of psoriasis: therapeutic targets, pharmacodynamics and disease-drug-drug interaction implications. [PDF]
AAPS J, 2014 Wang J, Wang YM, Ahn HY.
europepmc +1 more source
Role of endogenous microbiota, probiotics and their biological products in human health. [PDF]
Nutrients, 2013 Howarth GS, Wang H.
europepmc +1 more source